RadChat

Rad Chat is the multi-award winning, first therapeutic radiographer led oncology podcast, designed for cancer patients, healthcare professionals, academics, and researchers. Naman Julka-Anderson and Jo McNamara are both therapeutic radiographers who have unique backgrounds, bringing specialist knowledge and skills to the conversation. Their guests include people living with and beyond cancer, healthcare professionals, researchers, and leaders within healthcare.

Visit podcast website

Download MedPod Learn

Make more of your medical podcast listening. Browse and listen free in MedPod Learn; Premium adds structured notes, self-test questions, reflection and exportable learning records.
This website provides podcast information and episode previews.
Try MedPod’s learning tools with a St Emlyn’s sample
October 30, 2026

Rad Chat Live #28 at the MR Linac Consortium 2026 in Montreal: Dr. John Christodouleas - Advances in MR-Linac Treatments

Changing brain anatomy can undermine generous glioblastoma treatment margins; regular adaptation improves targeting and reduces normal-brain dose, while reported findings remain separate from a randomised trial in development and imaging choice follows the clinical problem.

October 30, 2026

Rad Chat Live #27 at the MR Linac Consortium 2026 in Montreal: Sneha Cloake - Evolution of MR-Linac

Resource-intensive adaptive radiotherapy needs continuing training and workflow development; repeat teaching visits address missed learning, while experienced clinical peers provide practice-based support that extends beyond the vendor's remit.

October 30, 2026

Rad Chat Live #26 at the MR Linac Consortium 2026 in Montreal: Erik Geerlof - MR-Linac Business Manager Elekta

Online adaptive radiotherapy discussions need to weigh normal-tissue toxicity alongside tumour control and distinguish patient benefit from departmental efficiency; peer exchange supports shared learning, but vendor support alone cannot create collaboration.

October 30, 2026

Rad Chat Live #25 at the MR Linac Consortium 2026 in Montreal: Lisa McDaid - The Christie MR-Linac

MR-linac pathways combine diagnostic and therapeutic radiography skills, competency training and safety governance; coordinated clinician attendance supports one-stop cord compression care, while delegation of tasks does not transfer clinical responsibility.

October 30, 2026

Rad Chat Live #24 at the MR Linac Consortium 2026 in Montreal: Dr. Ilker Tosun - Clinical Marketing at Elekta

Functional MRI biomarkers may help investigate residual tumour after radiotherapy, separately from online motion tracking; proposed treatment changes remain possibilities rather than established protocols, and clinical input helps connect technology development with practice.

October 30, 2026

Rad Chat Live #23 at the MR Linac Consortium 2026 in Montreal: Dr. Ying Zheng - AI in Adaptive Radiotherapy Work Flows

Reference-plan settings influence daily adaptive radiotherapy, while pancreatic anatomy affects planning complexity; an AI checker derived from historical plans and review comments remains preliminary, with testing limited to a couple of simulated cases.

October 30, 2026

Rad Chat Live #22 at the MR Linac Consortium 2026 in Montreal: Dr. Mischa de Ridder - Glottis MR-Linac Treatment

Five-fraction MR-guided treatment for early glottic cancer trades longer sessions for fewer visits while monitoring internal movement; limited acute toxicity in ten patients does not establish long-term safety or superiority over alternative approaches.

October 30, 2026

Rad Chat Live #21 at the MR Linac Consortium 2026 in Montreal: Constantin Schorling - Cardiac Motion Management

Real-time cardiac and respiratory motion tracking aims to maintain radiotherapy target coverage, although clinical benefits remain research goals; ventricular tachycardia treatment presents the additional challenge that the target and organ at risk occupy the same heart.

October 30, 2026

Rad Chat Live #20 at the MR Linac Consortium 2026 in Montreal: Edoardo Salmeri - Medical Engineering and Medical Affairs

Daily MR images provide longitudinal information about tumour changes, but their meaning and use in treatment selection remain research questions; clinical visits help engineers translate patient-care needs into relevant technical development.

October 30, 2026

Rad Chat Live #19 at the MR Linac Consortium 2026 in Montreal: Dr. Detsky - Groundbreaking Glioblastoma MR-Linac Research

Daily imaging and adaptive replanning allow smaller margins in glioblastoma treatment while tracking tumour migration; early single-arm findings address marginal-recurrence safety, but historical comparisons do not establish improved survival.